AAP Grand Rounds Subscribe to Pediatrics in Review
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
 Vol. 20 No. 2, August 2008
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Rathore, M. H.
Right arrow Articles by Barton, L. L.
PubMed
Right arrow Articles by Rathore, M. H.
Right arrow Articles by Barton, L. L.

AAP Grand Rounds 20:15-16 (2008)
© 2008 American Academy of Pediatrics

INFECTIOUS DISEASES

Antibiotic Therapy for Streptococcal Pharyngitis Revisited

Source: Lennon DR, Farrell E, Martin DR, et al. Once-daily amoxicillin versus twice-daily penicillin V in group A β-haemolytic streptococcal pharyngitis. Arch Dis Child. 2008;93(6):474–478; doi:10.1136/adc.2006.113506[Abstract/Free Full Text]

The first 20% of the full text of this article appears below.


PICO

Question: Among school-age children with group A β-hemolytic streptococcal pharyngitis, does once-daily amoxicillin eradicate GAβHS as well as twice-daily penicillin?

Question type: Therapy

Study design: Prospective, randomized, non-blinded trial

 

Investigators from New Zealand enrolled children 5–12 years of age in a prospective, randomized (1:1), nonblinded study to determine if oral once-daily amoxicillin (1500 mg if >30 kg, 750 mg if ≤30 kg; n=177) was noninferior to oral twice-daily penicillin V (500 mg if >30 kg, 250 mg if ≤ 30 kg; n=176) for treatment of group A β-hemolytic streptococcal (GAβHS) pharyngitis. Both drugs were given for 10 days.

Children were enrolled between May 1996 and November 1998 if they presented with a sore throat and signs and symptoms suggestive of acute pharyngitis at a school clinic and had a throat culture positive for GAβHS. Noninferiority was defined as the upper confidence limit (CL) of a less than 10% difference in treatment effect between the two arms.

Exclusion criteria included receipt of antibiotics in the previous 72 hours; history of acute rheumatic fever (ARF), cardiac or kidney disease; a rash suggestive of scarlet fever . . . [Full Text of this Article]

Mobeen H. Rathore, MD, FAAP1 and Leslie L. Barton, MD, FAAP2
1 Pediatric Infectious Diseases and Immunology, University of Florida, Jacksonville, FL
2 University of Arizona School of Medicine, Tucson, AZ

 





HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Academy of Pediatrics.